Modra
Modra Pharmaceuticals Announces First Patients Treated in Phase IIa Metastatic Breast Cancer Trial 22 march 2019
Modra Pharmaceuticals Expands Management Team and Provides Corporate Update 19 december 2018
Phase I results with ModraDoc006/r published in the European Journal of Cancer 14 october 2017
Honorary award for CMO of Modra, Jan Schellens 25 september 2017
Modra Pharmaceuticals Announces Start of Phase II Study for its Lead Oral Chemotherapy in Patients with Metastatic Prostate Cancer 14 june 2017

Meet Us At

30 august 2017

Meet us at one of the following events:

 

BioCapital Europe 2018, February 6, 2018, Amsterdam, Netherlands

 

BIO-Europe Spring, March 12 -14, 2018, Amsterdam, Netherlands

 

 

 

 

 

 




News

Modra Pharmaceuticals Announces First Patients Treated in Phase IIa Metastatic Breast Cancer Trial
Read more

Modra's Unique Approach

improving patient lives    
Learn more

Events

Meet us at one of the following events:      
Read more